SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
Mandyan
Lv1
80 积分
2024-03-10 加入
最近求助
最近应助
互助留言
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment
4小时前
待确认
Exploring the efficacy of PARP inhibitors in metastatic castration-resistant prostate cancer with homologous recombination repair alteration: a meta-analysis based on subgroups and reconstructed individual patient data
13天前
已完结
HER2 and urothelial carcinoma: current understanding and future directions
17天前
已完结
Clinical efficacy and safety of Panax notoginseng saponins in treating chronic obstructive pulmonary disease with blood hypercoagulability: A meta-analysis of randomized controlled trials
1个月前
已完结
Meta-analysis of Targeted Therapies in EGFR-mutated Non–Small Cell Lung Cancer
1个月前
已完结
Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta‐analysis
1个月前
已完结
Efficacy and safety of enfortumab vedotin in the treatment of advanced urothelial carcinoma: a systematic review and meta-analysis
1个月前
已完结
Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials
1个月前
已完结
Enfortumab vedotin prolongs overall survival in metastatic urothelial carcinoma following pembrolizumab therapy in real‐world data
1个月前
已完结
Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
1个月前
已完结
没有进行任何应助
感谢
7个月前
找到了【积分已退回】
7个月前
不用了【积分已退回】
8个月前
找到了【积分已退回】
8个月前
找到了【积分已退回】
8个月前
不需要【积分已退回】
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论